Most Recent
Bondholders of Axsesstoday are seeking to expand their claims in a class action against the collapsed asset finance lender and its accountant PricewaterhouseCoopers, alleging PwC kept investors in the dark about a spike in the company's arrears ratio prior to issuing a $50 million bond prospectus.
Venture capitalist Dr Elaine Stead is seeking indemnity costs after being awarded $280,000 in her defamation case against Nine-owned Fairfax, which she accuses of rejecting several settlement offers with "bugger off letters" and engaging in a "petulant campaign" of media coverage post-judgment.
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer's expert witnesses.
A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a "wreckage" of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.
Two NAB units have indicated they will seek to dismiss a lawsuit over alleged MySuper mismanagement which the court recently ruled was not validly commenced as a class action if the lead applicant fails in his bid to replead.
The High Court has dismissed an appeal by Westpac challenging a ruling that found the bank breached its duties to customers by providing personal financial advice as part of a telephone campaign encouraging customers to roll over external superannuation accounts.
Chinese businessman Dr Chau Chak Wing has been awarded $590,000 in a Federal Court judgment that found an ABC Four Corner's report contained "untrue and seriously defamatory imputations" about alleged espionage, bribery of UN leaders, and links to the Chinese Communist Party.
The funder behind a class action against McMillan Shakespeare has warned against the court beating it up like a 'pinata' in a settlement approval hearing in which the judge expressed "real concerns" about the portion of a $9.5 million settlement earmarked for group members.
The judge who found J&J's pelvic mesh implants defective in a high stakes class action ruling mde a "pervasive error" in disregarding the knowledge and views of the applicants' doctors, an appeals court has heard.
A $100 million shareholder class action against supermarket giant Woolworths has settled for $44.5 million, a few days before a 15-day trial was set to begin.